NOBIAS THERAPEUTICS
Nobias Therapeutics is a developer of rare pediatric disease drugs intended to cure rare illnesses in children. It focuses on discovering the genetic basis for rare diseases and develops drugs that can intervene in the affected pathways, enabling parents to help their infants become healthier.
NOBIAS THERAPEUTICS
Industry:
Health Care Medical Therapeutics
Address:
Princeton, New Jersey, United States
Country:
United States
Total Employee:
1+
Status:
Active
Total Funding:
3.75 M USD
Similar Organizations
Empirica Therapeutics
Empirica Therapeutics is a developer of therapeutic drugs designed to treat aggressive forms of cancer.
Genase Therapeutics
Genase Therapeutics is the developer of therapeutic products intended to treat solid tumors.
Pharmetrics
Pharmetrics provides a collaborative approach to create medications tailored to the therapeutic needs of individual patients.
PowderMed
PowderMed developed the Particle Mediated Epidermal Delivery (PMED) technology.
Rainier Therapeutics
Rainier Therapeutics is a developer of cancer therapeutics technology intended to offer advanced targeted therapy for bladder cancer.
Spokane Therapist
Spokane Therapist is a dedicated group of mental health professions serving the Spokane community with compassion and empathetic care.
Theranostec
Theranostec is a developer of effective and safe anti-cancer therapies.
Tiburio Therapeutics
Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.
Validus Cellular Therapeutics
Validus Cellular Therapeutics is a developer of therapeutic solutions for treating infectious diseases.
Wings Therapeutics
Wings Therapeutics is a developer of genetic skin disease drug designed to improve the healing and integrity of the skin.
Current Employees Featured
Investors List
Domain Associates
Domain Associates investment in Series A - Nobias Therapeutics